admin, tekijä sivustolla MVision AI

MVision AI Contour+ (Guideline-Based AI Segmentation): highlights from an independent validation study using a comprehensive and curated data set

Overall, 87% of the radiation oncologists who participated in the study gave the MVision AI Contour+ a score of 4 or 5 (minor or no…

Breast cancer radiotherapy – Exciting news about concomitant boost for hypofractionated treatment schedules

One of the important studies presented at the recent ASTRO 2023 meeting provided strong evidence for the safety and efficacy of concomitant boost during hypofractionated…

The clinician of the future – empowered by AI

Elsevier Health recently published a “Clinician of the future” report, based on the results of an online survey which gathered the perspectives of more than…

MVision AI is proud to announce the launch of the world’s first comprehensive Guideline-Based Segmentation (GBS™) solution for responsible radiation therapy contouring

HELSINKI, Finland – September 29, 2023 The launch of MVision AI’s GBS™ solution is timed to coincide with the release of two new products –…

Press Release: MVision AI is selected to provide its Contour+ solution by the Republic of Ireland’s Health Service Executive (HSE) for its first installation in the country

HELSINKI, Finland – September 14, 2023 MVision AI is experiencing ongoing and rapid growth within the health service sector globally. The company is delighted to…

Research Results of MVision AI Contour+ Models’ Clinical Evaluation

Key facts: Professionals working in 40 clinics from 31 countries assessed MVision AI’s Contour+ solution (Figure 1). More than 11 800 structures were evaluated on…

🎉 Exciting News: AI Auto-Contouring Recommended by NICE for Radiotherapy in the NHS! 🎉

We are thrilled to share a significant milestone that showcases the remarkable impact of innovation in radiotherapy. A number of AI auto-contouring tools, including MVision…

Press Release: MVision AI launches Contour+ auto-contouring to facilitate standardization and shorten time to treatment for cancer radiotherapy

HELSINKI, Finland – August 24, 2023 MVision AI is proud to announce the new software release version 1.2.4 of its guideline-based automatic segmentation service. Along…

Clinical User Experience with MVision AI

This is a webinar that you don’t want to miss! You’ll hear from an actual user and their clinical experience with MVision’s AI-powered software. Please…

The Importance of Guidelines and Standards in Radiotherapy

During the webinar, Jarkko discussed the critical role that guidelines and standards play in ensuring the safety and effectiveness of radiotherapy treatments. He shared insights…

Posts by admin